Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Campbell

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2019
Responsiveness of Serum C-Reactive Protein, Interleukin-17A, and Interleukin-17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double-Blind, Placebo-Controlled TrialsStefan Siebert, Kristen Sweet, Bidisha Dasgupta, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|February 1, 2023
Guideline No. 432a: Cervical Ripening and Induction of Labour - General InformationDebbie Robinson, Kim Campbell, Sebastian R Hobson, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|February 1, 2023
Guideline No. 432b: Cervical RipeningDebbie Robinson, Kim Campbell, Sebastian R Hobson, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|March 1, 2021
PATRO children, a multi-center, non-interventional study of the safety and effectiveness of Omnitrope<sup>®</sup> (somatropin) treatment in children: update on the United States cohortPhilippe Backeljauw, Bradley S Miller, Richard Levy, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 15, 2018
Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilarLee S Schwartzberg, Lincy S Lal, Sanjeev Balu, et al.
Journal of Medical Economics|August 22, 2019
Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphomaAli McBride, Andriy Krendyukov, Nicola Mathieson, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|September 24, 2021
Association Between Hyperoxemia and Increased Cell-Free Plasma Hemoglobin During Cardiopulmonary Bypass in Infants and ChildrenCatherine Gretchen, Hϋlya Bayir, Patrick M Kochanek, et al.
The Journal of Investigative Dermatology|August 2, 2016
HLA-C*06:02 Allele and Response to IL-12/23 Inhibition: Results from the Ustekinumab Phase 3 Psoriasis ProgramKatherine Li, C Chris Huang, Bruce Randazzo, et al.
Clinical and Experimental Immunology|January 12, 2022
Evaluation of a fit-for-purpose assay to monitor antigen-specific functional CD4+ T-cell subpopulations in rheumatoid arthritis using flow cytometry-based peptide-MHC class-II tetramer stainingSwati Patel, Nishta Ramnoruth, Pascale Wehr, et al.
Journal of Managed Care & Specialty Pharmacy|April 25, 2018
Clinical Outcomes of Treatment with Filgrastim Versus a Filgrastim Biosimilar and Febrile Neutropenia-Associated Costs Among Patients with Nonmyeloid Cancer Undergoing ChemotherapyLee S Schwartzberg, Lincy S Lal, Sanjeev Balu, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2019
Responsiveness of Serum C-Reactive Protein, Interleukin-17A, and Interleukin-17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double-Blind, Placebo-Controlled TrialsStefan Siebert, Kristen Sweet, Bidisha Dasgupta, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|February 1, 2023
Guideline No. 432a: Cervical Ripening and Induction of Labour - General InformationDebbie Robinson, Kim Campbell, Sebastian R Hobson, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|February 1, 2023
Guideline No. 432b: Cervical RipeningDebbie Robinson, Kim Campbell, Sebastian R Hobson, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|March 1, 2021
PATRO children, a multi-center, non-interventional study of the safety and effectiveness of Omnitrope<sup>®</sup> (somatropin) treatment in children: update on the United States cohortPhilippe Backeljauw, Bradley S Miller, Richard Levy, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 15, 2018
Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilarLee S Schwartzberg, Lincy S Lal, Sanjeev Balu, et al.
Journal of Medical Economics|August 22, 2019
Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphomaAli McBride, Andriy Krendyukov, Nicola Mathieson, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|September 24, 2021
Association Between Hyperoxemia and Increased Cell-Free Plasma Hemoglobin During Cardiopulmonary Bypass in Infants and ChildrenCatherine Gretchen, Hϋlya Bayir, Patrick M Kochanek, et al.
The Journal of Investigative Dermatology|August 2, 2016
HLA-C*06:02 Allele and Response to IL-12/23 Inhibition: Results from the Ustekinumab Phase 3 Psoriasis ProgramKatherine Li, C Chris Huang, Bruce Randazzo, et al.
Clinical and Experimental Immunology|January 12, 2022
Evaluation of a fit-for-purpose assay to monitor antigen-specific functional CD4+ T-cell subpopulations in rheumatoid arthritis using flow cytometry-based peptide-MHC class-II tetramer stainingSwati Patel, Nishta Ramnoruth, Pascale Wehr, et al.
Journal of Managed Care & Specialty Pharmacy|April 25, 2018
Clinical Outcomes of Treatment with Filgrastim Versus a Filgrastim Biosimilar and Febrile Neutropenia-Associated Costs Among Patients with Nonmyeloid Cancer Undergoing ChemotherapyLee S Schwartzberg, Lincy S Lal, Sanjeev Balu, et al.
Pageof 7